- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics of novel glucose-lowering drugs
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-19
DOI
10.1007/s00125-021-05402-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitors
- (2020) Anna Űrgeová et al. PHARMACOGENOMICS
- Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2020) Wendy K. Chung et al. DIABETOLOGIA
- Pharmacogenetics of Type 2 Diabetes—Progress and Prospects
- (2020) Yulia A. Nasykhova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes
- (2019) Mari Cassol Ferreira et al. Diabetology & Metabolic Syndrome
- GLP1R variant is associated with response to exenatide in overweight Chinese Type 2 diabetes patients
- (2019) Mingjun Yu et al. PHARMACOGENOMICS
- Diabetes: Is there a future for Pharmacogenomics guided treatment?
- (2019) Ewan R Pearson CLINICAL PHARMACOLOGY & THERAPEUTICS
- Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
- (2019) Chan Heo et al. Journal of Clinical Medicine
- Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
- (2019) Oana P Zaharia et al. Lancet Diabetes & Endocrinology
- The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
- (2019) Struan F.A. Grant DIABETES CARE
- Gut Microbiome and Response to Cardiovascular Drugs
- (2019) Sony Tuteja et al. Circulation-Genomic and Precision Medicine
- Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns
- (2018) João Pedro Ferreira et al. Circulation-Heart Failure
- Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy
- (2018) John M. Dennis et al. DIABETES CARE
- Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
- (2018) Jan W. Eriksson et al. DIABETOLOGIA
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- Patatin-like phospholipase domain–containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets
- (2018) Matthew A. Mitsche et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes
- (2018) Wolfgang Rathmann et al. DIABETOLOGIA
- Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes
- (2017) Heike Zimdahl et al. Pharmacogenetics and Genomics
- Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes
- (2017) Wen-Ling Liao et al. Oncotarget
- A missense variant inGLP1Rgene is associated with the glycaemic response to treatment with gliptins
- (2016) M. Javorský et al. DIABETES OBESITY & METABOLISM
- A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
- (2016) Eugene Han et al. MEDICINE
- Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
- (2016) Kaixin Zhou et al. NATURE GENETICS
- Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus
- (2016) Jazlina Liza Jamaluddin et al. PHARMACOGENOMICS
- Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide Treatment in Obese Patients With Diabetes Mellitus Type 2
- (2016) Daniel Antonio de Luis et al. JOURNAL OF INVESTIGATIVE MEDICINE
- A Common Susceptibility Gene for Type 2 Diabetes Is Associated with Drug Response to a DPP-4 Inhibitor: Pharmacogenomic Cohort in Okinawa Japan
- (2016) Uru Nezu Osada et al. PLoS One
- Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus
- (2015) Eef Hoeben et al. CLINICAL PHARMACOKINETICS
- Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
- (2015) Angus G. Jones et al. DIABETES CARE
- Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus
- (2015) Hiromi Kan et al. HEPATOLOGY RESEARCH
- In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans
- (2015) Stephan Francke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor
- (2015) Daniel Antonio de Luis et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
- (2015) Chia-Hung Lin et al. Journal of Diabetes Research
- KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus
- (2015) Polin Haghvirdizadeh et al. Journal of Diabetes Research
- Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin
- (2014) Heike Zimdahl et al. DIABETOLOGIA
- Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes
- (2014) Jazlina Liza Jamaluddin et al. PHARMACOGENOMICS
- Response to the dipeptidyl peptidase-4 inhibitors in Japanese patients with type 2 diabetes might be associated with a diplotype of two single nucleotide polymorphisms on the interleukin-6 promoter region under a certain level of physical activity
- (2014) Mizue Matsui et al. Journal of Diabetes Investigation
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway
- (2013) Leen M. ‘t Hart et al. DIABETES
- GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence
- (2012) A. R. Meloni et al. DIABETES OBESITY & METABOLISM
- G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1
- (2012) M. Ferdaoussi et al. DIABETOLOGIA
- CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects
- (2012) Andreas Holstein et al. Expert Opinion on Drug Metabolism & Toxicology
- Common Variants in the Type 2 Diabetes KCNQ1 Gene Are Associated with Impairments in Insulin Secretion During Hyperglycaemic Glucose Clamp
- (2012) Jana V. van Vliet-Ostaptchouk et al. PLoS One
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Diabetes-Associated SorCS1 Regulates Alzheimer's Amyloid- Metabolism: Evidence for Involvement of SorL1 and the Retromer Complex
- (2010) R. F. Lane et al. JOURNAL OF NEUROSCIENCE
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started